Vincere Biosciences is a company developing drugs that can restore mitochondrial quality to slow the progression of Parkinson’s disease and other age-related disorders where deficits in mitochondrial health is known to underlie the disease process.
There is no greater need in the world than extending human healthspan and as the human population ages, age-related diseases will become an unsustainable problem for humanity. Every member of the team is passionate about this cause, bringing decades of biology, technology, and drug discovery expertise to the fight. -- Spring Behrouz, PhD - CEO
Michael J Fox Foundation funds $1 million milestone-based project "Discovery and Development of Parkin Activators as Therapies for Parkinson's Disease"
Dr. Kalpana Merchant, PhD, former Chief Scientific Officer of Tailored Neuroscience Therapeutics at Eli Lilly, joins Vincere Biosciences as Chief Scientific Officer to develop novel therapeutics targeting mitochondrial qualitity control.
Vincere Biosciences launched by NeuroInitiative to develop small molecules for Parkinson's Disease
Bahareh (Spring) Behrouz
Board Member & Investor
Documentaries, videos and podcasts
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- Parkinson's diseaseA synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions.
- Drug discoveryThe process by which new candidate medications are discovered